-
Vaso-occlusive crises and costs of sickle cell disease in patients with comme...
Aim: To characterize vaso-occlusive crises (VOCs) and describe healthcare costs among commercially-insured, Medicaid-insured, and Medicare-insured patients with sickle cell... -
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with...
Aims: An increase in the prevalence of antimicrobial resistance among gram-negative pathogens has been noted recently.[1] A challenge in empiric treatment of complicated...